Copyright
©2014 Baishideng Publishing Group Inc.
World J Hepatol. Sep 27, 2014; 6(9): 652-659
Published online Sep 27, 2014. doi: 10.4254/wjh.v6.i9.652
Published online Sep 27, 2014. doi: 10.4254/wjh.v6.i9.652
Figure 2 Bubble plot of overall survival in patients receiving nucleos(t)ide analogue therapy or not after radical resection to treat hepatitis B virus-related hepatocellular carcinoma.
Bubble size reflects relative cohort size. aP < 0.05: NA group vs Control group. NA: Nucleos(t)ide analogue.
- Citation: Ke Y, Wang L, Li LQ, Zhong JH. Nucleos(t)ide analogues to treat hepatitis B virus-related hepatocellular carcinoma after radical resection. World J Hepatol 2014; 6(9): 652-659
- URL: https://www.wjgnet.com/1948-5182/full/v6/i9/652.htm
- DOI: https://dx.doi.org/10.4254/wjh.v6.i9.652